4.02
price up icon1.01%   0.04
after-market アフターアワーズ: 4.03 0.01 +0.25%
loading
前日終値:
$3.98
開ける:
$3.96
24時間の取引高:
29,387
Relative Volume:
0.24
時価総額:
$1.43B
収益:
$842.96M
当期純損益:
$-185.63M
株価収益率:
-7.644
EPS:
-0.5259
ネットキャッシュフロー:
$-228.52M
1週間 パフォーマンス:
-5.63%
1か月 パフォーマンス:
-4.74%
6か月 パフォーマンス:
-11.06%
1年 パフォーマンス:
-13.17%
1日の値動き範囲:
Value
$3.95
$4.03
1週間の範囲:
Value
$3.95
$4.415
52週間の値動き範囲:
Value
$2.84
$5.6405

Evotec Se Adr Stock (EVO) Company Profile

Name
名前
Evotec Se Adr
Name
セクター
Healthcare (1164)
Name
電話
-
Name
住所
-
Name
職員
4,766
Name
Twitter
Name
次回の収益日
2025-04-17
Name
最新のSEC提出書
Name
EVO's Discussions on Twitter

EVO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
EVO
Evotec Se Adr
4.02 1.42B 842.96M -185.63M -228.52M -0.5259
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
147.38 64.91B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.16 43.33B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.66 42.36B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.38 17.72B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
294.28 12.42B 2.99B 1.21B 1.13B 25.06

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-24 アップグレード Deutsche Bank Sell → Hold
2024-10-07 ダウングレード Jefferies Buy → Hold
2024-08-08 ダウングレード Deutsche Bank Hold → Sell
2024-07-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-07-11 ダウングレード Deutsche Bank Buy → Hold
2024-04-12 アップグレード Deutsche Bank Hold → Buy
2024-01-18 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-06-23 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-06-16 ダウングレード BofA Securities Buy → Neutral
2023-06-08 アップグレード Citigroup Neutral → Buy
2023-04-04 アップグレード Morgan Stanley Underweight → Equal-Weight
2022-12-09 開始されました H.C. Wainwright Buy
2022-11-16 ダウングレード Deutsche Bank Buy → Hold
2022-08-10 ダウングレード Morgan Stanley Overweight → Underweight
2022-03-02 再開されました Cowen Outperform
2022-01-07 再開されました Citigroup Neutral
すべてを表示

Evotec Se Adr (EVO) 最新ニュース

pulisher
Jul 30, 2025

Drug Discovery Platforms Market Size Expected to Reach USD 635.45 Million by 2034 - GlobeNewswire Inc.

Jul 30, 2025
pulisher
Jul 30, 2025

Evotec and Sandoz plan potential sale of Toulouse biologics site By Investing.com - Investing.com South Africa

Jul 30, 2025
pulisher
Jul 30, 2025

Evotec and Sandoz plan potential sale of Toulouse biologics site - Investing.com

Jul 30, 2025
pulisher
Jul 28, 2025

Evotec shares drop sharply after lowering 2025 revenue forecast - MSN

Jul 28, 2025
pulisher
Jul 26, 2025

Evotec SE (EVO) Stock Forecasts - Yahoo Finance

Jul 26, 2025
pulisher
Jul 25, 2025

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union - Ariva

Jul 25, 2025
pulisher
Jul 22, 2025

SAP Quarterly Statement Q2 202522.07.25News - Ariva

Jul 22, 2025
pulisher
Jul 21, 2025

Evotec stock tumbles after slashing 2025 revenue guidance - Investing.com Australia

Jul 21, 2025
pulisher
Jul 21, 2025

Evotec stock tumbles after slashing 2025 revenue guidance By Investing.com - Investing.com Canada

Jul 21, 2025
pulisher
Jun 04, 2025

8 New 4-Star Stocks - Morningstar

Jun 04, 2025
pulisher
May 24, 2025

Evotec SE ADR (EVO) Strikes $4.73: The Risk Seems Worthwhile At This Price - Stocksregister

May 24, 2025
pulisher
May 07, 2025

Evotec SE ADR earnings missed by $0.03, revenue fell short of estimates - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Evotec Ag Earnings Call: Mixed Sentiment Amid Growth - TipRanks

May 07, 2025
pulisher
May 07, 2025

Evotec AG Reports Q1 2025 Earnings and Strategic Progress - TipRanks

May 07, 2025
pulisher
Apr 28, 2025

Stock Information - Evotec

Apr 28, 2025
pulisher
Apr 24, 2025

Evotec shares surge 51% following InvestingPro’s undervalued signal By Investing.com - Investing.com

Apr 24, 2025
pulisher
Apr 18, 2025

Evotec SE ADR earnings beat by $0.08, revenue topped estimates - Investing.com Australia

Apr 18, 2025
pulisher
Apr 17, 2025

Evotec SE Reports Strong Q4 2024 and New Strategy - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec Ag’s Earnings Call: Growth Amid Challenges - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec: Management Streamlines Strategy to Refocus on Core Strengths Amid Biologics Momentum - Morningstar

Apr 17, 2025
pulisher
Dec 29, 2024

Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha

Dec 29, 2024
pulisher
Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024
pulisher
Nov 22, 2024

Evotec SE withdraws acquisition offer - Investing.com

Nov 22, 2024
pulisher
Nov 17, 2024

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says - BNN Bloomberg

Nov 17, 2024
pulisher
Nov 15, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - MSN

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme Therapeutics stock sinks after confirming $2B Evotec buyout offer - Seeking Alpha

Nov 15, 2024
pulisher
Nov 06, 2024

Evotec Reports Strategic Growth Amidst Revenue Challenges - TipRanks

Nov 06, 2024
pulisher
Aug 23, 2024

Annual General Meeting - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Investor Relations - Evotec

Aug 23, 2024
pulisher
Aug 14, 2024

Earnings call: Evotec SE revises 2024 outlook amid market challenges - Investing.com

Aug 14, 2024
pulisher
Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar

Aug 13, 2024
pulisher
Jun 06, 2024

Healthcare Sector - Morningstar

Jun 06, 2024
pulisher
May 23, 2024

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges - Investing.com India

May 23, 2024
pulisher
Apr 24, 2024

Evotec: Still A Speculative Buy After A Significant Decline (NASDAQ:EVO) - Seeking Alpha

Apr 24, 2024
pulisher
May 17, 2023

Biosimilars Business News Recap: A New Partnership; Celltrion Wins Tenders - Center for Biosimilars

May 17, 2023
pulisher
Nov 10, 2022

Evotec SE ADR earnings, Revenue miss in Q3 By Investing.com - Investing.com India

Nov 10, 2022
pulisher
Jun 15, 2022

Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J - Yahoo Finance

Jun 15, 2022
pulisher
Jan 21, 2012

Together for Medicines That MatterEvotec - Evotec

Jan 21, 2012
pulisher
Sep 09, 2009

Evotec and Biogen Idec in research agreement - Proactive financial news

Sep 09, 2009

Evotec Se Adr (EVO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.57
price down icon 0.87%
$13.79
price up icon 0.80%
$8.81
price up icon 0.80%
drug_manufacturers_specialty_generic RDY
$13.94
price down icon 1.97%
$128.91
price up icon 0.53%
$294.28
price up icon 7.13%
大文字化:     |  ボリューム (24 時間):